# Protalix BioTherapeutics, Inc.: Form DEF 14A, filed Apr 29, 2024

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: DEF 14A
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 20:30 ET
- Period: 2024-06-27
- Accession: 0001104659-24-054084
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000110465924054084/tm2412127-1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000110465924054084/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000110465924054084/tm2412127-1_def14a.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-054084. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.